Thread by @GodfatherCap

$ENZC - 💥DUE DILIGENCE💥

This is the official thread that I will build on to capture all if the DD that others and I have done.

If anyone wonders where to find the DD on @enzolytics, point them here 👇

#1 - Here is a very comprehensive DD package created by a fellow shareholder. Besides including PRs all on one site, it has a lot of relevant videos to get you started

notion.so/ENZC-Latest-Ne…

$ENZC

#2 - their website is a great source if you are just getting your feet wet and want background on their technology, facilities, and executives
enzolytics.com

Make sure to also follow the executives on Twitter;

@enzolytics
@drgauravchandra (COO and VP of R&D)

$ENZC

#3 - @yatesinvesting has also compiled some of the DD into PowerPoint. It's a great summary of our milestones & Intel partnership. Link below:

1drv.ms/p/s!AseTmu6x6-…

#4 - On April 14th, 2021. CEO Charles Cotropia gave a very comprehensive summary of the company. This is a MUST watch.

Watch the video here:


Slides attached here:
notion.so/3763b79a47bd44…

$ENZC

#5 - On May 27, 2021 @intel Senior Leadership, @cliftonroberts and Nikhil Desphande, and @enzolytics COO, Dr. Gaurav Chandra had a panel discussion going over how $ENZC is using artificial intelligence to ultimately develop cures for diseases.


$ENZC

#6 - @intel published a whitepaper on how #AI can be used to develop CURES for many deadly diseases. This is an absolutely "must read" to understand how we will be pioneering Healthcare 2.0.

intel.com/content/www/us…

#7 - I have also interviewed and shared my opinions.

May 2021 Interview:


January 2021 Interview:


$ENZC

#8 - many articles have been written about us (not PRs)

6/5/21 microcapdaily.com/enzolytics-inc…
6/4/21 insiderfinancial.com/4-otc-stocks-t…
6/3/21 pennystocks.com/featured/2021/…
6/2/21 smallcapexclusive.com/enzolytics-enz…
5/23/21 insiderfinancial.com/enzolytics-enz…

Ty @iCoreCapital for compiling 🤌

$ENZC

#9 - Drug Development milestones.

On April 19th, 2021, the company issued a very comprehensive PR detailing their scientific milestones.

otcmarkets.com/stock/ENZC/new…

From this PR, I created a Pipeline chart to visualize. I will update this chart once per month;

#10 - This is basic but critical to understand. We have 3 platforms/technogies;

A) #AI to discover conserved sites on viruses

B) Human monoclonal antibodies to target a wide range of viruses. #HIV #COVID #HTLV etc (CURES)

C) IPF, which is used as an immuno-enhancer. (NOT CURE)

#11 - Using #AI the company intends on finding anf patenting conserved sites on all of these diseases.

We have only scratched the surface with #HIV #COVID and #HTLV. The company will attempt to develop CURES for many more, including #influenza (flu) #HSV (herpes), Ebola, etc.

#12 - The company has many partnerships and is looking to expand further with other pharmaceutical companies.

@GenScript - mAb production
@STCBiologics - Clinical Studies
@intel, @scientific_usa - AI
Uni Strasbourg - in-vitro studies
@CNPRCresearch - animal studies

#13 - Clone3 (CL3hmAb) is our mAb for #HIV. In-vitro studies show it to be unmatched at how effective it is. It's been studied in 6 universities all showing 95% effective against multiple strains of HIV. This therapy could be used to CURE/eradicate HIV.

#14 - CL3 was the first #HIV mAb, but not the last. With a cocktail of HIV antibodies HIV neutralization will likely be >95% effective now which promises to CURE the disease. Once commercial, this drug alone could bring in $105B within 11 years.

$ENZC

#15 - Our ITV-1 #IPF drug is going through EMA clinical trials. A smaller dose was trialed and discovered to be equally effective without any serious side effects when compared to Tamiflu. ITV-1 is an immuno supporter for #HIV patients, cold/flu and possibly #COVID

#16 - @enzolytics enters into first distribution and licensing agreement for their #ITV1 drug. Clinical trials are currently planned in Europe (EMA). Once approved, they will go for FDA approval as well.

otcmarkets.com/stock/ENZC/new…

#17 Regarding #SARSCoV2 monoclonal antibody CURE. Watch this video where they talk about engaging @US_FDA to fast track clinical studies. Should be done by year end. Animal trials start this month, June 2021. According to the vid.

Watch 38:55 - 41:00. 👀

#18 - During the most recent interview, COO addressed additional debilitating diseases and #Cancer was mentioned being a target. I suspect a antibody drug conjugate (ADC) but we don't have an official announcement yet.

Watch 42:42 - 44:20 👀

#19 - On June 7th, the company issues a PR highlighting a protocol to tackle existing and future pandemics, including the new #H10N3 bird flu. The company reaffirms objective to strengthen its IP Portfolio for various diseases and seeks partnerships.

otcmarkets.com/stock/ENZC/new…

#20 - Since reverse merging on December 1st, 2020, the company formed two subsidiaries; Virogentics and Biogenysis with intention to license their technologies. The company is actively seeking and dialouging with pharmaceutical companies, some that are milestone linked.

#21 - On Nov 10, 2020, Ronald Moss was appointed to ENZC medical advisory board. He's worked for major pharma company $MRK (NASDAQ), serves as Chief Medical officer at $ADMP (NASDAQ), and worked at @NIH. He has years of experience taking drugs through @US_FDA clinical trials.

#22 - On July 20th, 2021, the company announced a LOI with Creative Biolabs, inc. to license and commercialize the first treatment ever for the #HTLV Virus which impacts 10 - 20 Million people globally

#23 - On July 21st, 2021 the company announces a partnership with Lonza Group $LZAGF, a $54 Billion company, to expedite the development and production of HIV and SARS-CoV-2 monoclonal antibodies. The expectation is that time to clinical trials will be significantly reduced.

#24 - On July 22nd, 2021 @jameshicks held the 3rd Interview with @enzolytics followed by a zoomcall.

Watch the Recap here:


Notes from both meetings below:

Thank you @foxypenny for putting together you notes 🤌

#25 - Partnerships (UPDATE).